ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
ECTE was delisted on the 11th of July, 2016.
15 hedge funds and large institutions have $1.78M invested in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
9% less capital invested
Capital invested by funds: $1.97M → $1.78M (-$185K)
17% less funds holding
Funds holding: 18 → 15 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$33.3K |
| 2 |
Goldman Sachs
New York
|
+$7.71K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$367 |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$119 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NPC
National Planning Corporation
El Segundo,
California
|
-$18K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$381 |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$243 |
| 5 |
Morgan Stanley
New York
|
-$4 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PM
1
Platinum Management
New York
| $1.09M | – | – | – |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $332K | +$119 | +100 | +0% |
|
|
3
HighTower Advisors
Chicago,
Illinois
| $257K | -$381 | -320 | -0.2% |
|
|
4
Citadel Advisors
Miami,
Florida
| $38K | +$33.3K | +27,954 | New |
|
|
5
Goldman Sachs
New York
| $28K | +$7.71K | +6,471 | +42% |
|
6
Northern Trust
Chicago,
Illinois
| $16K | – | – | – |
|
7
Truist Financial
Charlotte,
North Carolina
| $16K | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $3K | -$243 | -204 | -7% |
|
|
BFA
9
BlackRock Fund Advisors
San Francisco,
California
| $2K | +$367 | +308 | +24% |
|
|
10
Morgan Stanley
New York
| $1K | -$4 | -3 | -0.4% |
|
|
EWM
11
Edge Wealth Management
New York
| $1K | – | – | – |
|
12
US Bancorp
Minneapolis,
Minnesota
| $1K | – | – | – |
|
13
Geode Capital Management
Boston,
Massachusetts
| $70 | – | – | – |
|
|
NPC
14
National Planning Corporation
El Segundo,
California
| – | -$18K | -19,583 | Closed |
|
|
TRCT
15
Tower Research Capital (TRC)
New York
| – | -$3K | -2,301 | Closed |
|
ECTE Hedge Fund Activity: Q1 2016 in Review
15 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) for Q1 2016, worth a combined $1.78M — down 9.4% from $1.97M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ECTE and 1 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $33.3K. The largest seller was National Planning Corporation, exiting entirely with an estimated $18K sold.
- 15 institutional investors held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) as of Q1 2016, down from 18 in Q4 2015.
- Funds reported $1.78M of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) stock for Q1 2016, down 9.4% quarter-over-quarter.
- 1 fund opened new ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) positions in Q1 2016 and 4 closed out, a net change of -3 holders.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) buyer in Q1 2016 was Citadel Advisors, an estimated $33.3K added.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) seller in Q1 2016 was National Planning Corporation, an estimated $18K sold.
Based on aggregated 13F filings for Q1 2016.